DeepMed Research

Huazhong University Of Science And Technology Press Co., Ltd.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparison of Fascial Iliac Compartment Block and Quadratus Lumborum Block for Hip Surgery

Not Applicable

Conditions: Analgesia

Interventions: Procedure: Fascial iliac compartment block
Procedure: Quadratus lumborum block

First Posted Date: 2021-04-01

Last Posted Date: 2021-06-08

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 100

Registration Number: NCT04827121

Locations: 🇨🇳
Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Intravenous Dexamethasone and Dexmedetomidine on the Analgesic Efficacy of Erector Spinae Plane Block

Not Applicable

Completed

Conditions: Dexamethasone
Dexmedetomidine
Nerve Block

Interventions: Drug: Dexamethasone and dexmedetomidine
Drug: Dexmedetomidine
Other: Ultrasound-guided lumbar erector spinae plane block
Other: PCIA

First Posted Date: 2021-02-23

Last Posted Date: 2022-03-29

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 120

Registration Number: NCT04767256

Locations: 🇨🇳
Union Hospital, Wuhan, Hubei, China

Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies

Early Phase 1

Conditions: Diffuse Large B-cell Lymphoma (DLBCL)
Peripheral T-cell Lymphomas (PTCL)
Mantle Cell Lymphoma (MCL)
Chronic Lymphocytic Leukemia (CLL)
Follicular Lymphoma (FL)
CD5+ Relapsed/Refractory Hematopoietic Malignancies

Interventions: Biological: CT125A cells
Drug: Cyclophosphamide, fludarabine

First Posted Date: 2021-02-23

Last Posted Date: 2021-02-23

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 18

Registration Number: NCT04767308

Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery

Phase 3

Recruiting

Conditions: Uterine Cervical Neoplasms
Cervical Cancer

Interventions: Drug: Adjuvant chemotherapy

First Posted Date: 2021-02-02

Last Posted Date: 2021-02-02

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 340

Registration Number: NCT04733820

Locations: 🇨🇳
Tongji Hospital, Wuhan, Hubei, China

Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline

Phase 3

Active, not recruiting

Conditions: Uterine Cervical Neoplasms
Cervical Cancer

Interventions: Drug: Paclitaxel or docetaxel + Cisplatin or carboplatin

First Posted Date: 2021-01-26

Last Posted Date: 2024-11-01

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 306

Registration Number: NCT04723875

Locations: 🇨🇳
Qilu Hospital, Shandong University, 107 West Wenhua Road, Ji'nan, Shandong, China
🇨🇳
Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
🇨🇳
Tongji Hospital, Wuhan, Hubei, China

MED90 of Ropivacaine for Peripheral Nerve Block on Posture-evoked Pain in Spinal Anesthesia Positioning

Not Applicable

Conditions: Hip Fractures

Interventions: Procedure: Fascia iliaca block
Procedure: Femoral nerve block
Procedure: Pericapsular nerve group block (PENG block)

First Posted Date: 2021-01-12

Last Posted Date: 2022-02-09

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 180

Registration Number: NCT04705974

Locations: 🇨🇳
Department of Anesthesiology, Tongji Hospital, Wuhan, Hubei, China

Plasma Biomarkers of Cardiopulmonary Bypass Induced Acute Respiratory Distress Syndrome (CPB-ARDS)

Completed

Conditions: Acute Respiratory Distress Syndrome

First Posted Date: 2021-01-06

Last Posted Date: 2022-12-13

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 525

Registration Number: NCT04696172

Locations: 🇨🇳
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
🇨🇳
Wuhan Asia Heart Hospital, Wuhan, Hubei, China

A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

Phase 2

Conditions: Biliary Tract Cancer

Interventions: Drug: Nab-paclitaxel + Cisplatin
Drug: Gemcitabine + Cisplatin

First Posted Date: 2020-12-31

Last Posted Date: 2020-12-31

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 100

Registration Number: NCT04692051

Locations: 🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Circulating Extracellular Exosomal Small RNA as Potential Biomarker for Human Pancreatic Cancer

Not Applicable

Conditions: Pancreas Adenocarcinoma

Interventions: Procedure: Venous sampling

First Posted Date: 2020-11-19

Last Posted Date: 2020-11-19

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 102

Registration Number: NCT04636788

Locations: 🇨🇳
Tongji Hospital, Tongji Medical College, HUST, Wuhan, Hubei, China

The Effect of Acupuncture on IVF Pregnancy Outcomes for Women With RIF

Not Applicable

Recruiting

Conditions: Repeated Implantation Failure

Interventions: Device: acupuncture and IVF
Device: sham acupuncture and IVF

First Posted Date: 2020-08-31

Last Posted Date: 2021-04-23

Lead Sponsor: Huazhong University of Science and Technology

Target Recruit Count: 514

Registration Number: NCT04533295

Locations: 🇨🇳
Tongji Hospital,Tongji medical college,HUST, Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy